TORRANCE, Calif.--(BUSINESS WIRE)--Celprogen Inc., a leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have successfully finished printing 3D Brains from brain stem cells for studying neurological disease stages. The poster on this work will be presented at the Annual Neuroscience meeting in San Diego, Nov 3rd 2018. The 3D printed human brain was utilized for studying "The role of Microglia activation and deactivation in neurological diseases." Celprogen has been able to identify and characterize 11 lead compounds that are potential drug candidates for Alzheimer’s, Parkinson’s and Glioblastoma patients.
The present invention relates to 3D organ printing programs at Celprogen that identifies potential future use in transplant of major organ systems. At present, Celprogen is validating the 3D human printed heart, pancreas, liver, hair follicle and brain for toxicology and drug discovery research.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company since 2002 , which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at http://www.celprogen.com.
